جميع الدراسات
التوظيفالمرحلة 2تدخلي

To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva

This research study is focused on Fibrodysplasia Ossificans Progressiva (FOP), a very rare condition where soft tissues turn into bone over time. The study is testing a new drug, INCB000928, to see if it can help slow down or stop this process. We will also check if the medication is safe to use and how well people tolerate it. This is a "Phase 2" study, meaning we are exploring its effectiveness and safety in more detail after initial tests. Participants will be given either the new drug or a placebo (a dummy pill with no medicine) in a way that neither they nor the doctors know who gets what. This helps us accurately compare the real effects of the drug. The information gained will be vital for developing future treatments for FOP.

نظرة سريعة

الحالة
التوظيف
المرحلة
المرحلة 2
الراعي
شركة إنسايت
الهدف من التسجيل
98
ابدأ
05 May 2022
التاريخ المتوقع للانتهاء
20 Jan 2033

ما هو موضوع هذه الدراسة؟

This study is all about understanding and potentially treating Fibrodysplasia Ossificans Progressiva (FOP). FOP is a very rare genetic condition that causes muscle and other connective tissues to gradually turn into bone, leading to a permanent loss of movement. It's a challenging condition, and currently, there aren't many effective treatments available.

Researchers are testing a new medication called INCB000928. The main goal is to see if this drug can help people with FOP. We want to find out if it can reduce the formation of new bone, ease symptoms, and generally improve the lives of those affected. We will also carefully check if the medication is safe to use and if people can take it without too many unwanted side effects. This kind of research is essential for finding better ways to manage and potentially even cure FOP in the future.

This specific study is called a "Phase 2" trial. This means we're moving past the very first safety checks and are now looking more closely at how well the drug works and its overall safety in a larger group of people. Participants will be randomly assigned to receive either the new drug or a placebo – a tablet that looks the same but contains no active medicine. This 'blinded' approach helps us get the most accurate results by preventing anyone's expectations from affecting the outcome. The study is a crucial step in bringing new hope to the FOP community.

النقاط الرئيسية

  • Tests a new drug (INCB000928) for Fibrodysplasia Ossificans Progressiva (FOP).
  • Aims to check if the drug is effective and safe.
  • Compares the new drug to a placebo (dummy pill).
  • Open to both adults and children aged 2 and up.
  • Involves regular clinic visits, blood tests, and special body scans.
  • Your participation helps advance FOP research, but no guaranteed personal benefit.

من قد يكون مؤهلاً؟

To join this study, you need to have a confirmed diagnosis of Fibrodysplasia Ossificans Progressiva (FOP). We're looking for both males and females. The study includes different age groups, starting from children as young as 2 years old, up to adults aged 99.

There are also some important safety considerations. For instance, you shouldn't be pregnant or breastfeeding. If you're able to have children, or capable of fathering them, you'll need to agree to use effective birth control throughout the study. Your FOP symptoms should also be at a level that allows you to safely take part in the study and undergo necessary scans.

There are certain health conditions or situations that would prevent you from joining, such as having certain infections like HIV, Hepatitis B, or C. The study team will review all your medical information carefully to make sure it's safe and appropriate for you to participate.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. Do I have a diagnosis of FOP?
  2. Am I aged between 2 and 99 years old?
  3. Am I willing to use birth control if I can have children?
  4. Can I have body scans without needing to be put to sleep?
  5. Do I have any serious infections like HIV or Hepatitis?
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

Taking part in this study would involve regular visits to the clinic for check-ups and assessments. You would be given either the new study medication, INCB000928, or a placebo (a tablet with no active medicine) to take regularly, as instructed by the study team. Neither you nor your study doctor will know which one you are receiving – this is to ensure the results are as fair and accurate as possible.

Throughout the study, you'll have specific tests, including low-dose body scans (CT scans) that help us see any changes in your bones, but these won't involve your head. You'll also have blood tests and other examinations to monitor your health and how the medication is affecting you. We won't ask you to be put to sleep (intubated) for any of these scans. The total duration of your involvement in the study will be explained in detail by the study team, including how long you'll be taking the medication and how many follow-up appointments you'll have.

المخاطر والفوائد المحتملة

Participating in this study might offer some potential benefits, as you would receive a new, investigative medication that could possibly help with your FOP, or contribute to finding a treatment for others in the future. However, there's no guarantee the treatment will work for you. There are always potential risks with any medication, including side effects, which the study team will fully explain. You might also experience discomfort from clinic visits or procedures like blood tests and scans. Remember, your participation is completely voluntary, and you have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

المواقع (24)

  • مايو كلينك روتشستر
    الرمز البريدي المؤكد
    روتشستر، الولايات المتحدة· التوظيف
  • Children'S Hospital of Philadelphia
    الرمز البريدي المؤكد
    فيلادلفيا، الولايات المتحدة· التوظيف
  • Penn Medicine - Perelman Center For Advanced Medicine
    الرمز البريدي المؤكد
    فيلادلفيا، الولايات المتحدة· نشط غير مجند
  • مستشفى إيطاليانو دي بوينس آيرس
    الرمز البريدي المؤكد
    بوينس آيرس، الأرجنتين· نشط غير مجند
  • Royal North Shore Hospital
    الرمز البريدي المؤكد
    سانت ليوناردز، أستراليا· مكتمل
  • Murdoch Children'S Research Institute
    الرمز البريدي المؤكد
    باركفيل، أستراليا· نشط غير مجند
  • Albert Einstein Israelite Hospital
    الرمز البريدي المؤكد
    ساو باولو، البرازيل· نشط غير مجند
  • University Health Network Toronto General Hospital
    الرمز البريدي المؤكد
    تورونتو، كندا· نشط غير مجند
  • Centro de Estudios Reumatologicos
    الرمز البريدي المؤكد
    سانتياغو، تشيلي· نشط غير مجند
  • Beijing Childrens Hospital Capital Medical University
    الرمز البريدي المؤكد
    بكين، الصين· التوظيف
  • Tongji Hospital of Tongji University
    الرمز البريدي المؤكد
    Shanghai, China· التوظيف
  • Shanghai Childrens Medical Center
    الرمز البريدي المؤكد
    Shanghai, China· التوظيف

أسئلة شائعة

What is FOP?

FOP (Fibrodysplasia Ossificans Progressiva) is a rare condition where soft tissues like muscles and tendons gradually turn into bone, leading to movement problems.

What is INCB000928?

INCB000928 is a new medication being tested to see if it can help slow down or stop the extra bone formation in people with FOP.

Will I get the real medicine or a dummy pill?

You will be randomly given either the new medicine or a placebo (a dummy pill), and neither you nor your doctor will know which one you are receiving.

ما هي دراسة 'المرحلة 2'؟

A Phase 2 study checks how well a new medicine works and continues to monitor its safety after initial testing in smaller groups.

Can children join this study?

Yes, children from 2 years old up to adults are included in different age groups within the study.

كيفية معرفة المزيد

مركز اتصال شركة إنسايت (الولايات المتحدة)

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

هل أنت مهتم بالمشاركة؟

سجل اهتمامك

شارك تفاصيلك وفريق البحث لـ "To Assess the Efficacy, Safety, and Tolerability of INCB0009… "سيتواصل معك إذا كنت مؤهلاً. تحدث دائمًا إلى طبيبك قبل الموافقة على المشاركة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.